Email Updates
Study
Prescribing errors with low-molecular-weight heparins.
October 13, 2021
Slikkerveer M, van de Plas A, Driessen JHM, et al. J Patient Saf. 2021;17(7):e587-e592.
Anticoagulants, such as low-molecular-weight heparin (LMWH), are known to be high-risk for adverse drug events. This cross-sectional study identified prescribing errors – primarily lack of dosage adjustment for body weight and/or renal function – among one-third of LMWH users admitted to one hospital over a five-month period.
Related Resources From the Same Author(s)
Related Resources
Patient Safety Innovations
Remote Response Team and Customized Alert Settings Help Improve Management of Sepsis
See More About The Topic
